This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Eiji Kobayashi, MD, PhD; Michio Miyata, MD, PhD
Omiya, Japan

Arch Surg. 1995;130(6):676-677.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with interest the report by Liu et al¹ in the January issue of the ARCHIVES. They performed heterotopic allotransplantation of whole spleen in six patients with hemophilia A or advanced hepatocellular carcinoma. The results showed that the allografted spleen produced coagulating factor VIII and suggested that splenic allotransplantation had a positive effect against unresectable hepatocellular carcinoma. We congratulate the successful cases in the former group based on many scientific works.²

However, the effect of the transplanted spleen on patients with malignant disease is still controversial. From our clinical data on total gastrectomy with splenectomy in patients with advanced gastric cancer and metastatic lymph nodes of the splenic hilum, the positive effect of splenectomy is considered for curative procedures, but its effect on patient prognosis is controversial because no randomized study has been done and there is a lack of knowledge about its mechanism. We are looking . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?